Nice — I pulled recent market reports, company filings and industry press and assembled a compact, source-backed briefing for the Empty / Hard Capsules (Empty Capsules) market with vendor references including public values where available, plus Recent Developments, Drivers, Restraints, Regional split, Emerging Trends, Top Use Cases, Major Challenges, Attractive Opportunities and Key expansion factors.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Empty Capsules market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Empty Capsules market.

Read complete report at: https://www.thebrainyinsights.com/report/empty-capsules-market-12710

I cite the sources inline so you can copy them into slides or a spreadsheet.

1) Quick market snapshot (consensus ranges)

Global market size estimates cluster in the ~USD 3.1–3.5 billion (2024/2025) range with forecasts into the USD ~4–7+ billion band by the early-to-mid 2030s (CAGR commonly ~5–9% depending on publisher and scope — e.g., whether enteric/advanced capsules are separated).

2) Key vendor references — companies with public values / useful metrics

(If a vendor does not disclose a capsule-only revenue, I note that and cite the best public proxy.)

Lonza (Capsugel) — Lonza is the global market leader via its Capsugel portfolio and discloses CHI/health-related segment results in its Annual Report (Lonza 2024 Annual Report used as the public company source). Lonza/Capsugel is repeatedly listed as the #1 supplier in market reports.
Roquette (Qualicaps) — after Roquette’s acquisition of Qualicaps, Roquette reported Pharma Solutions sales €818 million (2024) (this includes Qualicaps / capsule & equipment sales; useful proxy for capsule business scale inside Roquette).
ACG (Associated Capsules / ACG Worldwide) — ACG is consistently ranked among the largest capsule makers (integrated global presence); Indian legal/registry sources list ACG Associated Capsules revenue figures (company disclosures and market profiles). ACG also publishes its global capability footprint.
Qualicaps (brand; now part of Roquette) — Qualicaps is a leading hard-capsule maker (historic net sales figures for the Qualicaps group / predecessor reported in company transfer notes), now consolidated in Roquette’s Pharma Solutions line.
Suheung Co., Ltd. — major South Korean capsule manufacturer (listed among top global suppliers in multiple industry lists).
Nitta Gelatin / Natural Capsules / CapsCanada / Bright Pharma Caps / Shanxi Guangsheng / Roxlor / Fuji Capsule — frequently named in market reports as leading regional/global suppliers (many are private; some publish annual capacity or corporate revenue in filings or market-profile sites). Use vendor filings for line-item capsule numbers when you need precise per-company capsule revenue.

Short note: most capsule suppliers are private or sell capsules as part of broader pharma/food ingredient groups, so few publish a capsule-only revenue line. Where groups disclose a pharma segment (e.g., Roquette’s €818M Pharma Solutions), I used that as the best publicly-reported proxy. Market reports (IMARC, Fortune Business Insights, MarketsandMarkets, Future Market Insights, Spherical Insights) list the canonical vendor set above.

3) Recent developments (2023 → mid-2025)

Continued consolidation and acquisitions (strategic M&A and vertical integration by larger ingredient/packaging groups), and Roquette’s consolidation of Qualicaps into its Pharma Solutions business is an example of scale moves in the market.
Product innovation: growth of specialty / enteric / targeted-release capsules (e.g., plant-based HPMC, pullulan, Capsugel Enprotect-type offerings) to support sensitive actives (peptides, probiotics) and clean-label demand.
Demand boost from nutraceuticals / supplements + ageing population driving higher volumes alongside pharma demand for advanced drug-delivery formats.

4) Drivers

Rising global consumption of dietary supplements / nutraceuticals and growth in OTC/consumer health.
Biopharma interest in targeted / enteric / delayed-release oral delivery (capsules that protect acid-sensitive actives).
Shift to plant-based / vegetarian capsules (HPMC, pullulan) for clean-label, halal/vegetarian demand.

5) Restraints

Price sensitivity in high-volume commodity gelatin capsule segments (especially in cost-sensitive nutraceuticals).
Raw-material availability and cost (gelatin supply linked to collagen/animal sources; HPMC/pullulan supply chains can also constrain).
Regulatory/quality compliance costs for pharma-grade capsules (GMP, stability and regulatory filings).

6) Regional segmentation (high level)

North America: large consumer-health market, high adoption of speciality capsules and pharma-grade supply; significant share of revenue in several reports.
Europe / Japan: strong demand for vegetarian capsules and high-quality pharmaceutical supplies (Qualicaps, Roquette footprint).
Asia-Pacific (China, India, South Korea): biggest production base and fastest growth (many Chinese and Indian suppliers, plus large manufacturers such as ACG, Shanxi, CapsCanada presence in North America). APAC is both a production hub and rising domestic demand market.

7) Emerging trends

Enteric & advanced-release capsules for biologics / peptides (growing R&D and product launches).
Plant-based capsule adoption (HPMC, pullulan) for vegetarian/halal claims and clean-label positioning.
Capsule personalization & on-demand manufacturing (smaller batch, clinical trial sizes — trend in early-stage pharma development).

8) Top use cases

Pharmaceutical oral solid dosage (prescription drugs, delayed-release formulations).
Nutraceuticals / dietary supplements (vitamins, herbal extracts, probiotics).
Clinical trial / R&D encapsulation (small sizes, specialized capsules for investigational products).

9) Major challenges

Maintaining consistent quality at scale (GMP for pharma vs. high-volume nutraceutical runs).
Managing raw-material volatility (gelatin sourcing, vegetable polymer costs).
Differentiating commodity capsule business vs. high-margin specialty capsules to capture better profitability.

10) Attractive opportunities

Premium / specialty capsule segments (enteric, targeted release, clean-label plant-based) — higher margins and differentiated value.
Contract capsule filling and clinical trial services for CDMOs / small pharma players.
Geographic expansion & localized supply in APAC / LATAM as nutraceutical/pharma manufacturing grows in those regions.

11) Key factors that will expand the market

Sustained nutraceutical / supplement demand and wider OTC consumption globally.
Technological adoption of enteric/targeted capsules and plant-based materials.
Industry consolidation & scale (larger groups acquiring niche capsule makers to add capabilities and geographic footprint).

12) Primary sources (select, high-impact)

IMARC Group — Empty Capsules Market Report (market size & regional split).
Fortune Business Insights — Empty Capsules Market forecast.
MarketsandMarkets / PR coverage — market sizing and vendor lists.
Roquette (Qualicaps) FY 2024 / Pharma Solutions sales €818M (Qualicaps consolidation).
Grand-style industry lists / vendor profiles (ACG, Lonza Capsugel, Qualicaps, Suheung, CapsCanada, Nitta Gelatin, Shanxi etc.).

If you’d like, I can do one of the following right now (I’ll assemble it immediately with source links):

A) Build a vendor CSV/Excel (15–20 suppliers) listing: company name, country, the best public metric I could find (capsule-only revenue / segment revenue / capacity / corporate revenue as proxy), and the exact source link for each cell.
B) Produce a 1-page PowerPoint slide summarising market size ranges, top vendors (with cited values) and 3 strategic takeaways.
C) Do a deep dive on enteric / advanced capsules (market size for enteric capsules, top suppliers of enteric/pH-sensitive capsules, recent product launches such as Capsugel Enprotect, and clinical/regulatory implications).

Which do you want me to build now?

Empty Capsules Market Size | Growth & Forecast to 2034